August 7, 2025

TotalEnergies SE (TTE) Investor Outlook: Solid Dividend Yield and 14.51% Potential Upside

TotalEnergies SE (TTE), a major player in the global energy sector, offers a compelling investment opportunity with its robust dividend yield and significant potential upside. With a market capitalization of..

CS Disco, Inc. (LAW) Stock Analysis: With a 47% Potential Upside, Is This Tech Stock a Buy?

CS Disco, Inc. (NYSE: LAW), a key player in the legal technology sector, is garnering increased attention from investors due to its innovative AI-powered legal solutions and a notable potential..

Sprout Social, Inc (SPT) Stock Analysis: Exploring a 66.56% Potential Upside in the Tech Sector

Sprout Social, Inc (NASDAQ: SPT), a prominent player in the technology sector, specializes in providing a comprehensive web-based social media management platform. This Chicago-based company has carved out a niche..

Sanara MedTech Inc. (SMTI) Stock Analysis: Unlocking a 99.59% Upside Potential

Sanara MedTech Inc. (NASDAQ: SMTI), a healthcare stalwart in the medical instruments & supplies industry, has been making waves with its innovative approach to wound care and surgical solutions. Based..

Olema Pharmaceuticals, Inc. (OLMA): A Biotech Stock with a Potential 396% Upside

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) has recently captured the attention of investors with its substantial potential upside and robust analyst ratings. This San Francisco-based clinical-stage biopharmaceutical company is dedicated to..

Yalla Group Limited (YALA) Stock Analysis: Navigating a Promising Path in the MENA Tech Space

Yalla Group Limited (NYSE: YALA), a prominent social networking and gaming platform in the Middle East and North Africa (MENA) region, has been capturing investor attention amidst its impressive stock..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: Unpacking a Potential 37% Upside in the Biotech Sector

In the ever-evolving landscape of biotechnology, Palvella Therapeutics, Inc. (NASDAQ: PVLA) is making waves with its innovative approach to rare genetic skin diseases. With a market cap of $431.95 million,..

NETCLASS TECHNOLOGY INC (NTCL) Stock Analysis: Navigating Volatility in China’s EdTech Arena

NetClass Technology Inc (NASDAQ: NTCL) is carving out its niche in the rapidly evolving technology sector with its focus on online professional education platforms. Operating across the People’s Republic of..

Compass Therapeutics, Inc. (CMPX) Investor Outlook: A Potential 339.86% Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector may want to take a closer look at Compass Therapeutics, Inc. (NASDAQ: CMPX). This Boston-based, clinical-stage biopharmaceutical company is making waves..

Outset Medical, Inc. (OM) Stock Analysis: Exploring an 86% Potential Upside with Innovative Hemodialysis Solutions

Outset Medical, Inc. (NASDAQ: OM), a trailblazer in the healthcare sector, is making waves with its innovative hemodialysis solutions. Based in San Jose, California, Outset Medical is revolutionizing the medical..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Eyeing a 211% Upside with Strong Buy Ratings

Abeona Therapeutics Inc. (NASDAQ: ABEO) is a name that has been buzzing in the biotechnology sector, particularly for investors seeking high-growth opportunities. With a current market capitalization of $326.89 million,..

Phathom Pharmaceuticals (PHAT) Stock Analysis: Unveiling a Potential 128.97% Upside in the Biotech Sector

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is capturing the attention of investors with its significant growth potential in the biotechnology sector. Specializing in treatments for gastrointestinal diseases, Phathom is poised to..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a 164.98% Potential Upside in the Biotech Arena

CytomX Therapeutics, Inc. (CTMX) stands as a compelling investment opportunity within the biotechnology sector, particularly for investors with a keen interest in oncology-focused innovations. Headquartered in South San Francisco, California,..

Benitec Biopharma Inc. (BNTC) Stock Analysis: A Promising 120% Upside in the Biotech Sector

Benitec Biopharma Inc. (NASDAQ: BNTC) is an intriguing player in the healthcare sector, specifically within the innovative biotechnology industry. As a clinical-stage company, Benitec is carving a niche in the..

Chevron Corporation (CVX) Stock Analysis: Exploring a 9.51% Potential Upside Amidst Market Volatility

Chevron Corporation (NYSE: CVX), a titan in the energy sector with a market capitalization of $310.64 billion, remains a compelling choice for investors seeking stability and income in the oil..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: A Promising 39% Upside in a Rapidly Growing Medical Device Sector

SANUWAVE Health, Inc. (NASDAQ: SNWV), a key player in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative approach to regenerative medicine. Based in..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking the 23.56% Potential Upside

For investors eyeing the biotechnology sector, Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) represents an intriguing prospect, boasting a compelling 23.56% potential upside according to recent analyst ratings. With a market cap..

Aura Biosciences, Inc. (AURA) Stock Analysis: Exploring a 214% Upside Potential on Innovative Cancer Therapies

Aura Biosciences, Inc. (NASDAQ: AURA), a prominent player in the biotechnology sector, is capturing significant attention from investors, thanks to its groundbreaking approach to cancer treatment and an eye-catching potential..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: Exploring a 5.22% Upside Amid Biotech Innovation

For investors with an eye on the biotechnology sector, iTeos Therapeutics, Inc. (NASDAQ: ITOS) presents an intriguing opportunity. With its current market capitalization of $446.57 million, iTeos is a clinical-stage..

Pacific Biosciences of California (PACB) Stock Analysis: Is a 48.91% Upside on the Horizon?

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a prominent player in the medical devices industry within the healthcare sector, is garnering attention with a potential upside of nearly 49%. This..

Search

Funds

August 7, 2025

Search

Funds

August 7, 2025

FTSE 100

Funds